At OMRF, Shah will serve as a technology development specialist.
Technology Ventures News
The drug treats fast-growing, deadly brain cancers with no effective treatment.
Seeking new ways to help patients manage lupus
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
Adakveo significantly reduces pain crises in sickle cell patients.
The funding will help bring Progentec’s tool for identifying lupus flare ups and a biomarker-based disease-activity index closer to commercialization.